why choose us

First received: August 02, 2024

Clinical Trial: Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Dose HRS-5041 in Healthy Caucasian Male Participants

Brief Summary: This is a phase 1, open-label, randomized study.The objective of this study is to evaluate the PK, safety and tolerability of orally administered single-dose HRS-5041 in healthy Caucasian male participants.

Read more